Digital Health Technology and Telemedicine-Based Hospital and Home Programs in Pulmonary Medicine During the COVID-19 Pandemic.
Journal
American journal of therapeutics
ISSN: 1536-3686
Titre abrégé: Am J Ther
Pays: United States
ID NLM: 9441347
Informations de publication
Date de publication:
03 Feb 2021
03 Feb 2021
Historique:
pubmed:
17
2
2021
medline:
17
3
2021
entrez:
16
2
2021
Statut:
epublish
Résumé
The current coronavirus disease 2019 (COVID-19) pandemic has caused a significant strain on medical resources throughout the world. A major shift to telemedicine and mobile health technologies has now taken on an immediate urgency. Newly developed devices designed for home use have facilitated remote monitoring of various physiologic parameters relevant to pulmonary diseases. These devices have also enabled home-based pulmonary rehabilitation programs. In addition, telemedicine and home care services have been leveraged to rapidly develop acute care hospital-at-home programs for the treatment of mild-to-moderate COVID-19 illness. The benefit of remote monitoring technologies on patient outcomes has not been established in robust trials. Furthermore, the use of these devices, which can increase the burden of care, has not been integrated into current clinical workflows and electronic medical records. Finally, reimbursement for these telemedicine and remote monitoring services is variable. Literature review. Advances in digital technology have improved remote monitoring of physiologic parameters relevant to pulmonary medicine. In addition, telemedicine services for the provision of pulmonary rehabilitation and novel hospital-at-home programs have been developed. These new home-based programs have been adapted for COVID-19 and may also be relevant for the management of acute and chronic pulmonary diseases after the pandemic. Digital remote monitoring of physiologic parameters relevant to pulmonary medicine and novel hospital-at-home programs are feasible and may improve care for patients with acute and chronic respiratory-related disorders.
Sections du résumé
BACKGROUND
BACKGROUND
The current coronavirus disease 2019 (COVID-19) pandemic has caused a significant strain on medical resources throughout the world. A major shift to telemedicine and mobile health technologies has now taken on an immediate urgency. Newly developed devices designed for home use have facilitated remote monitoring of various physiologic parameters relevant to pulmonary diseases. These devices have also enabled home-based pulmonary rehabilitation programs. In addition, telemedicine and home care services have been leveraged to rapidly develop acute care hospital-at-home programs for the treatment of mild-to-moderate COVID-19 illness.
AREAS OF UNCERTAINTY
UNASSIGNED
The benefit of remote monitoring technologies on patient outcomes has not been established in robust trials. Furthermore, the use of these devices, which can increase the burden of care, has not been integrated into current clinical workflows and electronic medical records. Finally, reimbursement for these telemedicine and remote monitoring services is variable.
DATA SOURCES
METHODS
Literature review.
THERAPEUTIC ADVANCES
UNASSIGNED
Advances in digital technology have improved remote monitoring of physiologic parameters relevant to pulmonary medicine. In addition, telemedicine services for the provision of pulmonary rehabilitation and novel hospital-at-home programs have been developed. These new home-based programs have been adapted for COVID-19 and may also be relevant for the management of acute and chronic pulmonary diseases after the pandemic.
CONCLUSION
CONCLUSIONS
Digital remote monitoring of physiologic parameters relevant to pulmonary medicine and novel hospital-at-home programs are feasible and may improve care for patients with acute and chronic respiratory-related disorders.
Identifiants
pubmed: 33590991
doi: 10.1097/MJT.0000000000001342
pii: 00045391-202104000-00007
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e217-e223Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555.
Mogayzel PJ, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187:680–689.
Adegunsoye A, Strek ME, Garrity E, et al. Comprehensive care of the lung transplant patient. Chest. 2017;152:150–164.
Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Heart J. 2016;37:67–119.
Aaron SD, Vandemheen KL, FitzGerald JM, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317:269.
Yawn BP, Enright PL, Lemanske RF, et al. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest. 2007;132:1162–1168.
Zibrak JD, O'Donnell CR, Marton K. Indications for pulmonary function testing. Ann Intern Med. 1990;112:763–771.
Aggarwal AN, Gupta D, Jindal SK. The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor. Chest. 2006;130:1454–1461.
Kruizinga MD, Essers E, Stuurman FE, et al. Technical validity and usability of a novel smartphone-connected spirometry device for pediatric patients with asthma and cystic fibrosis. Pediatr Pulmonol. 2020;55:2463–2470.
Loiseau C, Lemonnier F, Randrianarivelo O, et al. Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant. Eur Respir J. 2018;52:1702328.
Robson KS, West AJ. Improving survival outcomes in lung transplant recipients through early detection of bronchiolitis obliterans: daily home spirometry versus standard pulmonary function testing. Can J Respir Ther. 2014;50:17–22.
Huang C, Izmailova ES, Jackson N, et al. Remote FEV1 monitoring in asthma patients: a pilot study. Clin Transl Sci. 2020. doi:10.1111/cts.12901.
doi: 10.1111/cts.12901
Thap T, Chung H, Jeong C, et al. High-resolution time-frequency spectrum-based lung function test from a smartphone microphone. Sensors (Basel). 2016;16:1305.
Chung H, Jeong C, Luhach AK, et al. Remote pulmonary function test monitoring in cloud platform via smartphone built-in microphone. Evol Bioinforma Online. 2019;15:1176934319888904.
Goel M, Saba E, Maia S, et al. SpiroCall: measuring lung function over a phone call. In: Proceedings of the 2016 CHI Conference on Human Factors in Computing Systems. ACM; 2016:5675–5685. doi:10.1145/2858036.2858401.
Cheng Q, Juen J, Bellam S, et al. Predicting pulmonary function from phone sensors. Telemed J E Health. 2017;23:913–919.
Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59–99.
Merchant RK, Inamdar R, Quade RC. Effectiveness of population health management using the propeller health asthma platform: a randomized clinical trial. J Allergy Clin Immunol Pract. 2016;4:455–463.
Safioti G, Granovsky L, Li T, et al. A predictive model for clinical asthma exacerbations using albuterol eMDPI (ProAir digihaler): a twelve-week, open-label study. Iproceedings. 2019;5:e15173.
Moran C, Doyle F, Sulaiman I, et al. The INCATM (Inhaler Compliance AssessmentTM): a comparison with established measures of adherence. Psychol Health. 2017;32:1266–1287.
Sulaiman I, Greene G, MacHale E, et al. A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma. Eur Respir J. 2018;51:1–9.
Sportel ET, Oude Wolcherink MJ, van der Palen J, et al. Does immediate smart feedback on therapy adherence and inhalation technique improve asthma control in children with uncontrolled asthma? A study protocol of the IMAGINE I study. Trials. 2020;21:801.
Price DB, Buhl R, Chan A, et al. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial. Lancet Respir Med. 2018;6:29–39.
Vahlkvist S, Sinding M, Skamstrup K, et al. Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure. J Allergy Clin Immunol. 2006;117:1272–1276.
Essat M, Harnan S, Gomersall T, et al. Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review. Eur Respir J. 2016;47:751–768.
Zaidan MF, Reddy AP, Duarte A. Impedance oscillometry: emerging role in the management of chronic respiratory disease. Curr Allergy Asthma Rep. 2018;18:3.
Wong A, Hardaker K, Field P, et al. Home-based forced oscillation technique day-to-day variability in pediatric asthma. Am J Respir Crit Care Med. 2019;199:1156–1160.
Cho E, Wu JKY, Birriel DC, et al. Airway oscillometry detects spirometric-silent episodes of acute cellular rejection. Am J Respir Crit Care Med. 2020;201:1536–1544.
Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–64.
Rassouli F, Boutellier D, Duss J, et al. Digitalizing multidisciplinary pulmonary rehabilitation in COPD with a smartphone application: an international observational pilot study. Int J Chron Obstruct Pulmon Dis. 2018;13:3831–3836.
Bourne S, DeVos R, North M, et al. Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial. BMJ Open. 2017;7:e014580.
Calthorpe RJ, Smith S, Gathercole K, et al. Using digital technology for home monitoring, adherence and self-management in cystic fibrosis: a state-of-the-art review. Thorax. 2020;75:72–77.
Asthma Digital Study (ADS). Available at: https://clinicaltrials.gov/ct2/show/NCT04609644?term=apple+watch&cond=asthma&draw=2&rank=1.. Accessed December 10, 2020.
Venkataramanan R, Thirunarayan K, Jaimini U, et al. Determination of personalized asthma triggers from multimodal sensing and a mobile app: observational study. JMIR Pediatr Parent. 2019;2:e14300.
Available at: www.healthcareoriginals.com. Accessed December 10, 2020.
Tinschert P, Rassouli F, Barata F, et al. Prevalence of nocturnal cough in asthma and its potential as a marker for asthma control (MAC) in combination with sleep quality: protocol of a smartphone-based, multicentre, longitudinal observational study with two stages. BMJ Open. 2019;9:e026323.
Available at: www.vocalishealth.com. Accessed November 9, 2020.
Effing T, Monninkhof EM, van der Valk PD, et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007:CD002990. doi:10.1002/14651858.CD002990.pub2.
doi: 10.1002/14651858.CD002990.pub2
Fan VS, Gaziano JM, Lew R, et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med. 2012;156:673–683.
Talboom-Kamp EPWA, Holstege MS, Chavannes NH, et al. Effects of use of an eHealth platform e-Vita for COPD patients on disease specific quality of life domains. Respir Res. 2019;20:146.
Stamenova V, Liang K, Yang R, et al. Technology-enabled self-management of chronic obstructive pulmonary disease with or without asynchronous remote monitoring: randomized controlled trial. J Med Internet Res. 2020;22:e18598.
van Lieshout F, Yang R, Stamenova V, et al. Evaluating the implementation of a remote-monitoring program for chronic obstructive pulmonary disease: qualitative methods from a service design perspective. J Med Internet Res. 2020;22:e18148.
Shepperd S, Iliffe S. Hospital at home versus in-patient hospital care. Cochrane Database Syst Rev. 2005:CD000356. [PMID:16034853].
Shepperd S, Doll H, Angus RM, et al. Avoiding hospital admission through provision of hospital care at home: a systematic review and meta-analysis of individual patient data. CMAJ. 2009;180:175–182.
Levine DM, Ouchi K, Blanchfield B, et al. Hospital-level care at home for acutely ill adults: a randomized controlled trial. Ann Intern Med. 2020;172:77–85.
Lisker G, Narasimhan M, Greenberg H, et al. Ambulatory management of moderate to high risk COVID-19 patients: the coronavirus related outpatient work navigators (CROWN) protocol. Home Health Care Manag Pract. 2020. doi: 10.1177/1084822320964196.
doi: 10.1177/1084822320964196
Sitammagari K, Murphy S, Kowalkowski M, et al. Insights from rapid deployment of a virtual hospital as standard care during the COVID-19 pandemic. Ann Intern Med. 2020;11:M20–M4076.